PHBV/PLGA nanoparticles for enhanced delivery of 5-fluorouracil as promising treatment of colon cancer

References

• Acharya S, Sahoo SK. 2011. PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. Adv Drug Deliv Rev. 63:170–183.
   PubMed Web of Science ®Google Scholar
• Amin ML, Kim D, Kim S. 2016. Development of hematin conjugated PLGA nanoparticle for selective cancer targeting. Eur J Pharm Sci. 91:138–143.
   PubMed Web of Science ®Google Scholar
• Amjadi I, Rabiee M, Hosseini MS. 2013. Anticancer activity of nanoparticles based on PLGA and its co-polymer: in-vitro evaluation. Iran J Pharm Res. 12:623–634.
   PubMed Web of Science ®Google Scholar
• Chaturvedi K, Kulkarni AR, Aminabhavi TM. 2011. Blend microspheres of poly (3-hydroxybutyrate) and cellulose acetate phthalate for colon delivery of 5-fluorouracil. Ind Eng Chem Res. 50:10414–10423.
   Web of Science ®Google Scholar
• Coimbra PA, De Sousa HC, Gil MH. 2008. Preparation and characterization of flurbiprofen-loaded poly(3-hydroxybutyrate-co-3-hydroxyvalerate) microspheres. J Microencapsul. 25:170–178.
   PubMed Web of Science ®Google Scholar
• Dadashzadeh S, Derakhshandeh K, Shirazi FH. 2008. 9-Nitrocamptothecin polymeric nanoparticles: cytotoxicity and pharmacokinetic studies of lactone and total forms of drug in rats. Anticancer Drugs. 19(8):805–811.
   PubMed Web of Science ®Google Scholar
• Dobrovolskaia MA, McNeil SE. 2013. Understanding the correlation between in vitro and in vivo immunotoxicity tests for nanomedicines. J Control Release. 172:456–466.
   PubMed Web of Science ®Google Scholar
• Dubey RD, Saneja A, Qayum A, Singh A, Mahajan G, Chashoo G, Kumar A, Andotra SS, Singh SK, Singh G, Koul S, et al. 2016. PLGA nanoparticles augmented the anticancer potential of pentacyclic triterpenediol in vivo in mice. RSC Adv. 6:74586–74597.
   Web of Science ®Google Scholar
• Duran N, Alvarenga MA, Da Silva EC, Melo PS, Marcato PD. 2008. Microencapsulation of antibiotic rifampicin in poly(3-hydroxybutyrate-co-3-hydroxyvalerate). Arch Pharm Res. 31:1509–1516.
   PubMed Web of Science ®Google Scholar
• Eloy JO, Claro de Souza M, Petrilli R, Barcellos JP, Lee RJ, Marchetti JM. 2014. Liposomes as carriers of hydrophilic small molecule drugs: strategies to enhance encapsulation and delivery. Colloids Surf B Biointerfaces. 123:345–363.
   PubMed Web of Science ®Google Scholar
• Feczkó T, Tóth J, Dósa G, Gyenis J. 2011. Optimization of protein encapsulation in PLGA nanoparticles. Chem Eng Process Process Intens. 50:757–765.
   Web of Science ®Google Scholar
• Galindo-Rodriguez S, Allemann E, Fessi H, Doelker E. 2004. Physicochemical parameters associated with nanoparticle formation in the salting-out, emulsification-diffusion, and nanoprecipitation methods. Pharm Res. 21:1428–1439.
   PubMed Web of Science ®Google Scholar
• Gao H, Yang Z, Zhang S, Cao S, Shen S, Pang Z, Jiang X. 2013. Ligand modified nanoparticles increases cell uptake, alters endocytosis and elevates glioma distribution and internalization. Sci Rep. 3:2534.
   PubMed Web of Science ®Google Scholar
• Gunday Tureli N, Tureli AE, Schneider M. 2016. Optimization of ciprofloxacin complex loaded PLGA nanoparticles for pulmonary treatment of cystic fibrosis infections: Design of experiments approach. Int J Pharm. 515:343–351.
   PubMed Web of Science ®Google Scholar
• Haggar FA, Boushey RP. 2009. Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. Clin Colon Rectal Surg. 22:191–197.
   PubMedGoogle Scholar
• Halayqa M, Domańska U. 2014. PLGA biodegradable nanoparticles containing perphenazine or chlorpromazine hydrochloride: effect of formulation and release. Int J Mol Sci. 15:23909–23923.
   PubMed Web of Science ®Google Scholar
• Huang X, Dai Y, Cai J, Zhong N, Xiao H, McClements DJ, Hu K. 2017. Resveratrol encapsulation in core-shell biopolymer nanoparticles: Impact on antioxidant and anticancer activities. Food Hydrocolloids. 64:157–165.
   Web of Science ®Google Scholar
• Huang Y, Wu C, Liu Z, Hu Y, Shi C, Yu Y, Zhao X, Liu C, Liu J, Wu Y, Wang D. 2014. Optimization on preparation conditions of Rehmannia glutinosa polysaccharide liposome and its immunological activity. Carbohydr Polym. 104:118–126.
   PubMed Web of Science ®Google Scholar
• Jain AK, Swarnakar NK, Godugu C, Singh RP, Jain S. 2011. The effect of the oral administration of polymeric nanoparticles on the efficacy and toxicity of tamoxifen. Biomaterials. 32:503–515.
   PubMed Web of Science ®Google Scholar
• Jin H, Pi J, Yang F, Jiang J, Wang X, Bai H, Shao M, Huang L, Zhu H, Yang P, et al. 2016. Folate-chitosan nanoparticles loaded with ursolic acid confer anti-breast cancer activities in vitro and in vivo. Sci Rep. 6:30782.
   PubMed Web of Science ®Google Scholar
• Jin Y, Ren X, Wang W, Ke L, Ning E, Du L, Bradshaw J. 2011. A 5-fluorouracil-loaded pH-responsive dendrimer nanocarrier for tumor targeting. Int J Pharm. 420:378–384.
   PubMed Web of Science ®Google Scholar
• Joshi G, Kumar A, Sawant K. 2014. Enhanced bioavailability and intestinal uptake of Gemcitabine HCl loaded PLGA nanoparticles after oral delivery. Eur J Pharm Sci. 60:80–89.
   PubMed Web of Science ®Google Scholar
• Khan S, Chauhan N, Yallapu MM, Ebeling MC, Balakrishna S, Ellis RT, Thompson PA, Balabathula P, Behrman SW, Zafar N, Singh MM, et al. 2015. Nanoparticle formulation of ormeloxifene for pancreatic cancer. Biomaterials. 53:731–743.
   PubMed Web of Science ®Google Scholar
• Kouhi M, Prabhakaran MP, Shamanian M, Fathi M, Morshed M, Ramakrishna S. 2015. Electrospun PHBV nanofibers containing HA and bredigite nanoparticles: Fabrication, characterization and evaluation of mechanical properties and bioactivity. Compos Sci Technol. 121:115–122.
   Web of Science ®Google Scholar
• Kudarha R, Dhas NL, Pandey A, Belgamwar VS, Ige PP. 2015. Box-Behnken study design for optimization of bicalutamide-loaded nanostructured lipid carrier: stability assessment. Pharm Dev Technol. 20:608–618.
   PubMed Web of Science ®Google Scholar
• Le VM, Wang JJ, Yuan M, Nguyen TL, Yin GF, Zheng YH, Shi WB, Lang MD, Xu LM, Liu JW. 2015. An investigation of antitumor efficiency of novel sustained and targeted 5-fluorouracil nanoparticles. Eur J Med Chem. 92:882–889.
   PubMed Web of Science ®Google Scholar
• Li W, Jan Z, Ding Y, Liu Y, Janko C, Pischetsrieder M, Alexiou C, Boccaccini AR. 2016. Facile preparation of multifunctional superparamagnetic PHBV microspheres containing SPIONs for biomedical applications. Sci Rep. 6:23140.
   PubMed Web of Science ®Google Scholar
• Lin Q, Cai Y, Yuan M, Ma L, Qiu M, Su J. 2014. Development of a 5-fluorouracil-loaded PLGA microsphere delivery system by a solid-in-oil-in-hydrophilic oil (S/O/hO) novel method for the treatment of tumors. Oncol Rep. 32:2405–2410.
   PubMed Web of Science ®Google Scholar
• Manoochehri S, Darvishi B, Kamalinia G, Amini M, Fallah M, Ostad SN, Atyabi F, Dinarvand R. 2013. Surface modification of PLGA nanoparticles via human serum albumin conjugation for controlled delivery of docetaxel. Daru. 21:58.
   PubMed Web of Science ®Google Scholar
• Masood F, Chen P, Yasin T, Fatima N, Hasan F, Hameed A. 2013. Encapsulation of ellipticine in poly-(3-hydroxybutyrate-co-3-hydroxyvalerate) based nanoparticles and its in vitro application. Mater Sci Eng C Mater Biol Appl. 33:1054–1060.
   PubMed Web of Science ®Google Scholar
• Matsumura Y, Maeda H. 1986. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 46:6387–6392.
   PubMed Web of Science ®Google Scholar
• Mattos AC, Altmeyer C, Tominaga TT, Khalil NM, Mainardes RM. 2016. Polymeric nanoparticles for oral delivery of 5-fluorouracil: formulation optimization, cytotoxicity assay and pre-clinical pharmacokinetics study. Eur J Pharm Sci. 84:83–91.
   PubMed Web of Science ®Google Scholar
• Mendes JB, Riekes MK, de Oliveira VM, Michel MD, Stulzer HK, Khalil NM, Zawadzki SF, Mainardes RM, Farago PV. 2012. PHBV/PCL microparticles for controlled release of resveratrol: physicochemical characterization, antioxidant potential, and effect on hemolysis of human erythrocytes. ScientificWorldJournal. 2012:1.
   Web of Science ®Google Scholar
• Nair KL, Jagadeeshan S, Nair SA, Kumar GS. 2011. Biological evaluation of 5-fluorouracil nanoparticles for cancer chemotherapy and its dependence on the carrier, PLGA. Int J Nanomed. 6:1685–1697.
   PubMed Web of Science ®Google Scholar
• Oner M, Col AA, Pochat-Bohatier C, Bechelany M. 2016. Effect of incorporation of boron nitride nanoparticles on the oxygen barrier and thermal properties of poly(3-hydroxybutyrate-co-hydroxyvalerate). RSC Adv. 6:90973–90981.
   Web of Science ®Google Scholar
• Patel RR, Chaurasia S, Khan G, Chaubey P, Kumar N, Mishra B. 2016. Cromolyn sodium encapsulated PLGA nanoparticles: An attempt to improve intestinal permeation. Int J Biol Macromol. 83:249–258.
   PubMed Web of Science ®Google Scholar
• Patel A, Patel M, Yang X, Mitra AK. 2014. Recent advances in protein and Peptide drug delivery: a special emphasis on polymeric nanoparticles. Protein Pept Lett. 21:1102–1120.
   PubMed Web of Science ®Google Scholar
• Penaloza JP, Marquez-Miranda V, Cabana-Brunod M, Reyes-Ramirez R, Llancalahuen FM, Vilos C, Maldonado-Biermann F, Velasquez LA, Fuentes JA, Gonzalez-Nilo FD, et al. 2017. Intracellular trafficking and cellular uptake mechanism of PHBV nanoparticles for targeted delivery in epithelial cell lines. J Nanobiotechnol. 15:1.
   PubMed Web of Science ®Google Scholar
• Sadhukha T, Prabha S. 2014. Encapsulation in nanoparticles improves anti-cancer efficacy of carboplatin. AAPS PharmSciTech. 15:1029–1038.
   PubMed Web of Science ®Google Scholar
• Simion V, Stan D, Gan AM, Pirvulescu MM, Butoi E, Manduteanu I, Deleanu M, Andrei E, Durdureanu-Angheluta A, Bota M, et al. 2013. Development of curcumin-loaded poly(hydroxybutyrate-co-hydroxyvalerate) nanoparticles as anti-inflammatory carriers to human-activated endothelial cells. J Nanopart Res. 15:2108.
   Web of Science ®Google Scholar
• Tang Q, Wang Y, Huang R, You Q, Wang G, Chen Y, Jiang Z, Liu Z, Yu L, Muhammad S, Wang X. 2014. Preparation of anti-tumor nanoparticle and its inhibition to peritoneal dissemination of colon cancer. PLoS One. 9:e98455.
   PubMed Web of Science ®Google Scholar
• Tefas LR, Tomuta I, Achim M, Vlase L. 2015. Development and optimization of quercetin-loaded PLGA nanoparticles by experimental design. Clujul Med. 88:214–223.
   PubMedGoogle Scholar
• Vilos C, Morales FA, Solar PA, Herrera NS, Gonzalez-Nilo FD, Aguayo DA, Mendoza HL, Comer J, Bravo ML, Gonzalez PA, Kato S, et al. 2013. Paclitaxel-PHBV nanoparticles and their toxicity to endometrial and primary ovarian cancer cells. Biomaterials. 34:4098–4108.
   PubMed Web of Science ®Google Scholar
• Xiao B, Han MK, Viennois E, Wang L, Zhang M, Si X, Merlin D. 2015. Hyaluronic acid-functionalized polymeric nanoparticles for colon cancer-targeted combination chemotherapy. Nanoscale. 7:17745–17755.
   PubMed Web of Science ®Google Scholar
• Yadav AK, Agarwal A, Rai G, Mishra P, Jain S, Mishra AK, Agrawal H, Agrawal GP. 2010. Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil. Drug Deliv. 17:561–572.
   PubMed Web of Science ®Google Scholar
• Yang S, Zhang B, Gong X, Wang T, Liu Y, Zhang N. 2016. In vivo biodistribution, biocompatibility, and efficacy of sorafenib-loaded lipid-based nanosuspensions evaluated experimentally in cancer. Int J Nanomed. 11:2329–2343.
   PubMed Web of Science ®Google Scholar
• Yu Y, Lu Y, Bo R, Huang Y, Hu Y, Liu J, Wu Y, Tao Y, Wang D. 2014. The preparation of gypenosides liposomes and its effects on the peritoneal macrophages function in vitro. Int J Pharm. 460:248–254.
   PubMedGoogle Scholar
• Zeng C, Jiang W, Tan M, Yang X, He C, Huang W, Xing J. 2016. Optimization of the process variables of tilianin-loaded composite phospholipid liposomes based on response surface-central composite design and pharmacokinetic study. Eur J Pharm Sci. 85:123–131.
   PubMed Web of Science ®Google Scholar
• Zeng X, Morgenstern R, Nyström AM. 2014. Nanoparticle-directed sub-cellular localization of doxorubicin and the sensitization breast cancer cells by circumventing GST-Mediated drug resistance. Biomaterials. 35:1227–1239.
   PubMed Web of Science ®Google Scholar
• Zhu XH, Wang CH, Tong YW. 2009. In vitro characterization of hepatocyte growth factor release from PHBV/PLGA microsphere scaffold. J Biomed Mater Res A. 89:411–423.
   PubMed Web of Science ®Google Scholar
• Zhu D, Wu S, Hu C, Chen Z, Wang H, Fan F, Qin Y, Wang C, Sun H, Leng X, et al. 2017. Folate-targeted polymersomes loaded with both paclitaxel and doxorubicin for the combination chemotherapy of hepatocellular carcinoma. Acta Biomater. 58:399–412.
   PubMed Web of Science ®Google Scholar